United States · FDA National Drug Code directory
Clonazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67544-529_2458678c-6ce9-4fa4-976a-2c49b489a834
- Product NDC
- 67544-529
- Form
- TABLET
- Composition / generic term
- Clonazepam
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19960918
- Source listing expiry
- 20261231
Source-listed ingredients
- CLONAZEPAM — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (67544-529-10) · 67544-529-10
- 15 TABLET in 1 BOTTLE (67544-529-15) · 67544-529-15
- 28 TABLET in 1 BOTTLE (67544-529-28) · 67544-529-28
- 30 TABLET in 1 BOTTLE (67544-529-30) · 67544-529-30
- 45 TABLET in 1 BOTTLE (67544-529-45) · 67544-529-45
- 60 TABLET in 1 BOTTLE (67544-529-53) · 67544-529-53
- 84 TABLET in 1 BOTTLE (67544-529-54) · 67544-529-54
- 75 TABLET in 1 BOTTLE (67544-529-55) · 67544-529-55
- 90 TABLET in 1 BOTTLE (67544-529-60) · 67544-529-60
- 120 TABLET in 1 BOTTLE (67544-529-70) · 67544-529-70
- 150 TABLET in 1 BOTTLE (67544-529-75) · 67544-529-75
- 180 TABLET in 1 BOTTLE (67544-529-80) · 67544-529-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →